{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PAR.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PAR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAR.AU\",,,,,undefined,":{"symbol":"PAR.AU","market":"AU","secType":"STK","nameCN":"PARADIGM BIOPHARMACEUTICALS","latestPrice":0.22,"timestamp":1788138248520,"preClose":0.21,"halted":0,"volume":549537,"delay":0,"changeRate":0.047619047619047665,"nameEN":"PARADIGM BIOPHARMACEUTICALS","floatShares":353065639,"shares":606848701,"eps":-0.10495,"marketStatus":"Trading","change":0.01,"latestTime":"08-31 11:05:01 AEST","open":0.21,"high":0.22,"low":0.21,"amount":117283,"amplitude":0.047619,"askPrice":0.22,"askSize":21104,"bidPrice":0.215,"bidSize":72104,"shortable":3,"etf":0,"ttmEps":-0.10495,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788156000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.21,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":0.660188,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PAR.AU","preClose":0.21,"auctionPrice":0.21,"auctionVolume":84105,"auctionTime":1788134344610,"referenceTime":1787913003093,"auction":1,"marketStatus":"盘前竞价","timestamp":1788134344610}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAR.AU\",,,,,undefined,":{"symbol":"PAR.AU","floatShares":353065639,"roa":"-138.75%","roe":"-456.96%","lyrEps":-0.059684,"volumeRatio":0.660188,"shares":606848701,"dividePrice":0,"high":0.22,"amplitude":0.047619,"preClose":0.21,"low":0.21,"week52Low":0.135,"pbRate":"38.47","psRate":"15799.61","week52High":0.47,"institutionHeld":0,"latestPrice":0.22,"committee":0.547163,"eps":-0.10495,"divideRate":0,"volume":549537,"delay":0,"ttmEps":-0.10495,"open":0.21,"prevYearClose":0.34,"prevWeekClose":0.21,"prevMonthClose":0.165,"prevQuarterClose":0.165,"fiveDayClose":0.2,"twentyDayClose":0.175,"sixtyDayClose":0.145,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-02-06","symbol":"PAR.AU","defaultRemindTime":1738796400000,"type":"split","dateTimestamp":1738760400000,"forFactor":4,"toFactor":5,"ratio":0.8},{"market":"AU","date":"2022-08-17","symbol":"PAR.AU","defaultRemindTime":1660694400000,"type":"split","dateTimestamp":1660658400000,"forFactor":992772,"toFactor":1000000,"ratio":0.992772}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PAR.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620203940","title":"Paradigm Biopharmaceuticals Activates Additional Hong Kong Site For Global Phase Three Knee Osteoarthiritis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2620203940","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620203940?lang=en_us&edition=fundamental","pubTime":"2026-03-20 09:29","pubTimestamp":1773970163,"startTime":"0","endTime":"0","summary":"Paradigm Biopharmaceuticals  said an additional international clinical trial site in Hong Kong, the Hong Kong Center for Clinical Research, for its global phase three clinical study evaluating injectable pentosan polysulfate sodium in patients with knee osteoarthritis was activated, according to a Friday Australian bourse filing.The site started screening patients, with the study designed to enrol 466 participants globally.Three clinical trial sites in Moldova are expected to be activated in the coming weeks.Its shares rose 2% in recent trading on Friday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7067","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619557211","title":"PAR Technology Plans $225 Million Convertible Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2619557211","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619557211?lang=en_us&edition=fundamental","pubTime":"2026-03-13 05:48","pubTimestamp":1773352116,"startTime":"0","endTime":"0","summary":"PAR Technology  said late Thursday it plans to offer $225 million of convertible senior notes due 2031 in a private placement.The company may grant the initial purchaser an option to buy up to an additional $25 million of notes.The company said it plans to use the proceeds to repurchase part of its 1.50% convertible notes due 2027,buy back shares and support general corporate needs.Additionally, PAR Technology expects to repurchase up to $40 million of its shares from purchasers of the notes in privately negotiated transactions.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PAR.AU","BK4023","PAR","BK7508","BK7067","BK4157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616286483","title":"PAR Technology Launches Artificial Intelligence Suite for Convenience Retailers","url":"https://stock-news.laohu8.com/highlight/detail?id=2616286483","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616286483?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:10","pubTimestamp":1772543448,"startTime":"0","endTime":"0","summary":"PAR Technology  said Tuesday it has launched an artificial intelligence-powered product suite designed to provide real-time data insights and automate operations for convenience and fuel retailers.The new platform integrates directly into PAR's existing systems to reduce manual effort and eliminate the need for third-party applications, the company said.The software features modules that allow operators to generate data charts through a chat interface, automatically build promotional campaigns, and develop strategic plans using historical performance and external weather data, PAR said.Shares of the company were down 1.7% in recent Tuesday premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK4023","BK4157","BK7067","PAR","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":23,"code":"91000000","status":"200"}]}}